Register for AMRI’s free, live webinar, entitled “Trends in Quality Agreements & Communications: A CMO Perspective”, which will be held on Tuesday, June 23, 2015 at 11 a.m. ET
Outsourcing of all phases of pharmaceutical/biological development and manufacturing continues to rise. As drug development pipelines shift toward those requiring more complex and specialized capabilities, quality agreements and communication planning to avoid non-compliance and the costly ramifications are becoming more important. This webcast will review the FDA draft guidance document Contract Manufacturing Arrangements for Drugs: Quality Agreements and provide insights from the contract manufacturing organization (CMO) perspective into the integrated responsibilities and relationship of the contract provider and the drug sponsor.
Register for our free, live webinar, “Trends in Quality Agreements & Communications: A CMO Perspective”, to be held on Tuesday, June 23, 2015 at 11 a.m. ET. The presentation will be given by Milton Boyer, AMRI’s Senior Vice President of Drug Product Manufacturing.
Key Learning Objectives:
Contact Details:
Albany Molecular Research Inc.Email:clientservice@amriglobal.comWeb Address: Click here to register to watch our free webinar
Drug Solutions Podcast: Novel Drug Delivery Approaches: Refining AAV Vector Deliveries
May 30th 2025In this podcast episode, we discuss novel approaches to drug delivery, specifically regarding adeno-associated virus (AAV) vectors, as viewed by two industry experts who recently exhibited at the annual ASGCT meeting.
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Hesperos, Psilera Agree to Accelerate Organ-on-a-Chip Treatment for Frontotemporal Dementia
June 9th 2025The partnership leverages the Hesperos organ-on-a-chip platform in the preclinical development of Psilera’s lead compound targeting the progressive neurological disorder for which treatment options are few.